Drug
Aclidinium clinical trials
Includes 29 studies of Aclidinium bromide.
- studies test it
- 33
- open now
- 0
- in phase 3
- 20
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
33 studies that test it; most in 2009 (7)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 7 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 20
- Phase 4
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 29 · Other 4
AstraZeneca (28) · University of Dundee (2) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · University of Milan (1) · Daewoong Pharmaceutical Co. LTD. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses aclidinium is read from its arms, and is right about nine times in ten.
Testing it · 33
- Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD PatientsCompletedPhase 3AstraZenecaNCT03022097Written as Aclidinium bromide/formoterol Fixed-Dose Combination
- A Phase I, Open-Label, Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese ParticipantsCompletedPhase 1AstraZenecaNCT03276052Written as Aclidinium Bromide 400 μg
- Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC TrialCompletedPhase 4University of DundeeNCT02972476Written as Budesonide & formoterol fumarate and Aclidinium bromide
- Evaluation of Long-Acting Muscarinic Antagonists in COPDCompletedPhase 4University of DundeeNCT02039050Written as Aclidinium
- The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in SmokersCompletedPhase 3McGill University Health Centre/Research Institute of the McGill University Health CentreNCT03104634Written as Aclidinium bromide/formoterol fumarate dihydrate
- Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.CompletedPhase 4AstraZenecaNCT01966107Written as Aclidinium Bromide
- AMPLIFY - D6571C00001 Duaklir USA Phase III StudyCompletedPhase 3AstraZenecaNCT02796677Written as Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
- Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD PatientsCompletedPhase 4AstraZenecaNCT02424344Written as Aclidinium/Formoterol
- Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedPhase 3AstraZenecaNCT01437540Written as Aclidinium Bromide/Formoterol Fumarate
- Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3AstraZenecaNCT01572792Written as Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
- BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGHCompletedPhase 4AstraZenecaNCT02375724Written as Aclidinium Bromide
- Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)CompletedPhase 3AstraZenecaNCT01044459Written as Aclidinium Bromide 200 µg
- Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3AstraZenecaNCT01437397Written as Aclidinium Bromide/Formoterol Fumarate
- Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and PlaceboCompletedPhase 2AstraZenecaNCT01049360Written as Aclidinium 400 μg / Formoterol 12 μg
- Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol FumarateCompletedPhase 2AstraZenecaNCT01078623Written as Aclidinium 200 μg / formoterol 12 μg
- Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose CombinationCompletedPhase 3AstraZenecaNCT01462942Written as Aclidinium Bromide/Formoterol Fumarate
- Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)CompletedPhase 3AstraZenecaNCT01045161Written as Aclidinium bromide
- Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedPhase 2AstraZenecaNCT01120093Written as Aclidinium bromide 100 μg bid
- Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)CompletedPhase 3AstraZenecaNCT00891462Written as Aclidinium bromide
- Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)CompletedPhase 3AstraZenecaNCT00970268Written as Aclidinium bromide
See all 33 studies that test aclidinium →
As the comparator · 2 — what is tested is compared with aclidinium
Codes
What other systems call aclidinium · ClinicalTrials.gg INT016991
- UNII (FDA) K17VY42F6CACLIDINIUMConfirmed FDA, Wikidata
- RxNorm 1303098Confirmed FDA, Wikidata
- Wikidata Q521173aclidiniumConfirmed FDA, Wikidata
- NCI Thesaurus C79894AclidiniumOne source FDA
- DrugBank DB08897One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | K17VY42F6C | ACLIDINIUM | Confirmed FDA, Wikidata |
| RxNorm | 1303098 | — | Confirmed FDA, Wikidata |
| Wikidata | Q521173 | aclidinium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C79894 | Aclidinium | One source FDA |
| DrugBank | DB08897 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.